Tocilizumab
Indication
Systemic Juvenile Idiopathic Arthritis (NICE TA238)
NICE TA238 - Tocilizumab for the treatment of systemic juvenile idiopathic arthritis
Red
Brand:
Nice TA:
238
Commissioning responsibility:
CCG
PbR excluded:
Yes
BNF chapter:
Musculoskeletal system
Background
LSCMMG is adopting the local decision made prior to April 2013